Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Dec 10, 2019
| Rachel Schwartz
USMCA Trade Agreement: A Victory for America’s Patients
Press Release
Dec 9, 2019
| Rachel Schwartz
AAM Opposes the Lower Health Care Costs Act
Infographic
Nov 19, 2019
| Erica Klinger
USMCA: Nothing to See Here (Infographic)
Blog
Nov 19, 2019
| Jonathan Kimball
Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA
Blog
Nov 18, 2019
| Erica Klinger
Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner
Blog
Nov 14, 2019
| Erica Klinger
How Our Associate Members Make the World Healthier
Blog
Nov 11, 2019
| Erica Klinger
GRx+Biosims Year 2: The Recap
Press Release
Nov 1, 2019
| Rachel Schwartz
AAM Statement on Nomination of Dr. Stephen Hahn to FDA
Blog
Oct 29, 2019
| Rachel Schwartz
AAM Testimony on the Generic Global Supply Chain—Five Takeaways
Press Release
Oct 29, 2019
| Rachel Schwartz
AAM Statement on 2019 FDA Drug Shortages Task Force Report
Blog
Oct 29, 2019
| Jennifer Soup
GRx+Biosims: Back + Better Than Ever
Press Release
Oct 23, 2019
| Rachel Schwartz
AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action